ATE71527T1 - Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung. - Google Patents

Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung.

Info

Publication number
ATE71527T1
ATE71527T1 AT85850286T AT85850286T ATE71527T1 AT E71527 T1 ATE71527 T1 AT E71527T1 AT 85850286 T AT85850286 T AT 85850286T AT 85850286 T AT85850286 T AT 85850286T AT E71527 T1 ATE71527 T1 AT E71527T1
Authority
AT
Austria
Prior art keywords
production
activating composition
macrophage activating
macrophage
water
Prior art date
Application number
AT85850286T
Other languages
English (en)
Inventor
Karl Olov Peter Larm
James Hoffman
Rolf Seljelid
Jarl Bogwald
Original Assignee
Karl Olov Peter Larm
James Hoffman
Rolf Seljelid
Jarl Bogwald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Olov Peter Larm, James Hoffman, Rolf Seljelid, Jarl Bogwald filed Critical Karl Olov Peter Larm
Application granted granted Critical
Publication of ATE71527T1 publication Critical patent/ATE71527T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT85850286T 1984-09-19 1985-09-17 Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung. ATE71527T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8404699A SE466289B (sv) 1984-09-19 1984-09-19 Makrofagstimulerande komposition jaemte foerfarande foer dess framstaellning
EP85850286A EP0175667B1 (de) 1984-09-19 1985-09-17 Macrophage aktivierende Zusammensetzung und ein Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE71527T1 true ATE71527T1 (de) 1992-02-15

Family

ID=20357069

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85850286T ATE71527T1 (de) 1984-09-19 1985-09-17 Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung.

Country Status (6)

Country Link
US (1) US4795745A (de)
EP (1) EP0175667B1 (de)
JP (1) JPH072643B2 (de)
AT (1) ATE71527T1 (de)
DE (1) DE3585193D1 (de)
SE (1) SE466289B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
WO1992013896A1 (en) * 1991-02-01 1992-08-20 Bioglucans, L.P. Soluble glucans
DE4109282A1 (de) * 1991-03-21 1992-09-24 Stihl Maschf Andreas Schneidgeraet, insbesondere fuer graeser
JPH05262654A (ja) * 1992-03-18 1993-10-12 Kaken Pharmaceut Co Ltd 慢性疲労症候群治療剤
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
US5972717A (en) * 1995-05-10 1999-10-26 The Blood Center Research Foundation, Inc. Method and kit for detecting heparin induced thrombocytopenia
AU1672397A (en) * 1996-02-15 1997-09-02 Daiichi Pharmaceutical Co., Ltd. Brain activators
US5972718A (en) * 1996-02-28 1999-10-26 The Blood Center Research Foundation Method of detecting heparin-induced thrombocytopenia
US5843186A (en) * 1996-12-20 1998-12-01 Implemed, Inc. Intraocular lens with antimicrobial activity
GB2325233B (en) * 1997-05-16 2001-07-18 Norsk Hydro As Substrates having bound polysaccharides and bacterial nucleic acids
SE522410C2 (sv) * 1997-06-06 2004-02-10 Biotec Pharmacon Asa Beta 1-3-glukanderivat med immunomodulerande verkan
IL135148A0 (en) * 1997-10-03 2001-05-20 Galenica Pharmaceuticals Inc A polysaccharide conjugate and pharmaceutical compositions containing the same
GB0112649D0 (en) * 2001-05-24 2001-07-18 Isis Innovation Macrophage receptor
GB0211118D0 (en) 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
KR100563616B1 (ko) * 2004-05-20 2006-03-22 그린텍이십일 주식회사 베타글루칸 유도체, 그의 제조방법 및 베타글루칸유도체를 이용한 유착방지제, 그의 제조방법
US20060172438A1 (en) * 2004-10-04 2006-08-03 David Milunic Methods and kits for detecting heparin/platelet factor 4 antibodies
MX2007013725A (es) * 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
JP2007297322A (ja) * 2006-04-28 2007-11-15 Toyobo Co Ltd サイトカイン産生の促進方法
CN119530153B (zh) * 2024-12-18 2025-08-15 中国人民解放军军事科学院军事医学研究院 β-葡聚糖诱导巨噬细胞分泌的非炎性微囊泡在治疗炎症中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2560532C2 (de) * 1974-11-26 1988-11-10 Takeda Chemical Industries, Ltd., Osaka, Jp
FR2360310A1 (fr) * 1976-08-03 1978-03-03 Ajinomoto Kk Solution antitumorale aqueuse et son procede de preparation
US4156066A (en) * 1977-06-23 1979-05-22 Tyndale Plains - Hunter Ltd. Polyurethane polymers characterized by lactone groups and hydroxyl groups in the polymer backbone
JPS56115727A (en) * 1980-02-19 1981-09-11 Kuraray Co Ltd Carrier for immobilizing physiologically active substance
JPS5747493A (en) * 1980-09-02 1982-03-18 Fuji Photo Film Co Ltd Method of determining a trace amount of enzyme
JPS5840301A (ja) * 1981-09-03 1983-03-09 Takara Shuzo Co Ltd 抗腫瘍活性を有するβ−１，３−グルカン
SE456911B (sv) * 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma

Also Published As

Publication number Publication date
JPH072643B2 (ja) 1995-01-18
EP0175667A2 (de) 1986-03-26
SE466289B (sv) 1992-01-27
SE8404699D0 (sv) 1984-09-19
EP0175667B1 (de) 1992-01-15
DE3585193D1 (de) 1992-02-27
JPS61118320A (ja) 1986-06-05
EP0175667A3 (en) 1986-12-17
US4795745A (en) 1989-01-03
SE8404699L (sv) 1986-03-20

Similar Documents

Publication Publication Date Title
ATE71527T1 (de) Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung.
DE3580428D1 (de) Waessrige dispersion und verfahren zu ihrer herstellung.
ATE5782T1 (de) Bogenzusammenstellung und verfahren zu deren herstellung.
HUT34667A (en) Plant protectives containing pyridazinon-derivatives and process for the production of the agents
DE3883408D1 (de) Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
HUT38262A (en) Process for production of slowly releasing compositions
ATE83605T1 (de) Pestizide zusammensetzungen und verfahren zu ihrer herstellung.
FI883926L (fi) Menetelmä mikrokapseloimiseksi, mainitulla menetelmällä valmistettujen polymeerien käyttö sekä koosteet, jotka sisältävät mainitulla prosessilla valmistettuja polymeereja
DE69308531D1 (de) Cycloisomaltooligosaccharide; Enzym und Verfahren zu ihrer Herstellung, und Verfahren zur Herstellung von dem Enzym
ATE62480T1 (de) Aminoalkohol-derivate und verfahren zu ihrer herstellung.
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
AT388645B (de) Verfahren zur industriellen herstellung von pflanzen und anlage zur durchfuehrung des verfahrens
ATE51875T1 (de) Chemisches verfahren zur herstellung von antibiotikum l 17043.
HUT39073A (en) Insecticides containing as reagent derivatives of pirazolin and process for production of the reagent
DE3850891D1 (de) Verfahren zur Herstellung von hochtemperaturbeständigen Polymerisaten in Pulverform sowie Anlage zur Durchführung des Verfahrens.
DE3781350D1 (de) Angefeuchtete zusammensetzungen von hydratbildenden phosphaten und verfahren zu deren herstellung.
HUT39432A (en) Plant protection preparatives containg as reagent 2,4-diamino-6-halogene-5-alkyltio-piramidins and process for production of the reagent
ATE103899T1 (de) Zwischenprodukte und verfahren zu ihrer herstellung.
HUT36330A (en) Pesticide preparatives and process for production of the utilized as reagent derivatives of 4-pentin acid
ATE10492T1 (de) Stabile peroxydzusammensetzung und verfahren zu ihrer herstellung.
ATE78493T1 (de) Amphoterische staerke und verfahren zu deren herstellung.
ATE53020T1 (de) Verfahren zur herstellung von cis-bicyclo(3.3.0)- octylidenderivaten.
OA07656A (fr) Procédé de reconstruction de roches latériques et produit obtenu destiné au bâtiment.
ATE53580T1 (de) Kristallform von 1-benzhydryl-4-allyl-piperazin- dihydrochlorid und verfahren zu ihrer herstellung.
ATE56217T1 (de) Polyvinylzusammensetzung und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee